Reducing community dyspepsia drug costs: a controlled trial

Area of Science:

• Health Economics
• General Practice
• Gastroenterology

Background:

• Dyspepsia management represents a significant cost to the National Health Service, accounting for approximately 0.5% of its budget.
• A hypothesis suggests that optimizing dyspepsia care can lead to substantial reductions in associated drug expenditures.

Purpose of the Study:

• To evaluate if a comprehensive educational program for general practitioners can enhance dyspepsia management quality.
• To determine if this improved management effectively controls healthcare costs without elevating the need for endoscopic procedures.

Main Methods:

• A comparative study design was employed, delivering a multifaceted educational intervention to general practitioners in West Gloucestershire.
• Dyspepsia drug costs were the primary outcome, tracked via the Prescription Pricing Authority and compared between intervention and control (East Gloucestershire) groups.
• Secondary outcomes included endoscopy referral rates and gastrointestinal bleed admissions, recorded in the intervention area.

Main Results:

• The intervention group experienced a decline and stabilization in drug costs post-education, contrasting with a delayed peak in the control group.
• Statistical analysis revealed an estimated reduction of 57.9 pence per capita per half-year in the intervention group, a difference sustained for three years.
• This resulted in cumulative savings of £1.13 million, with stable upper gastrointestinal endoscopy referral rates observed throughout the study.

Conclusions:

• A multifaceted educational intervention for general practitioners is a proven strategy for improving dyspepsia care.
• This approach effectively controls drug costs associated with dyspepsia management.
• The intervention successfully managed costs without increasing the demand for diagnostic endoscopy.